The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

Nodularin     (2E)-9-[3- (diaminomethylideneamino) propyl]...

Synonyms: HSDB 7749, AC1O5MYK, LS-55952
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Nodularin

  • The present study characterizes the inhibitory effects of nodularin, a recently isolated hepatotoxic compound from the cyanobacterium Nodularia spumigena, on type 1 (PP1), type 2A, (PP2A), type 2B (PP2B), and type 2C (PP2C) protein phosphatases [1].
  • This peptide segment is not present in nodularin, a cyclic pentapeptide of similar toxicity [2].
  • A range of microcystin- and nodularin-containing laboratory strains and environmental samples of cyanobacteria were assayed by CIPPIA, and the results showed good correlation (R2 = 0.94, P < 0.00001) with the results of high-performance liquid chromatography with diode array detection for toxin analysis [3].
  • The picked Aphanizomenon colonies did not contain nodularin and the dissolved nodularin concentrations were below detection limit [4].
  • Many N. spumigena strains can produce nodularin, a hepatotoxic penta-peptide, which has caused several animal poisonings in the Baltic Sea area [5].
 

High impact information on Nodularin

  • The protein phosphatase (PP) inhibitors nodularin and microcystin-LR induced apoptosis with unprecedented rapidity, more than 50% of primary hepatocytes showing extensive surface budding and shrinkage of cytoplasm and nucleoplasm within 2 min [6].
  • To circumvent the inefficient uptake of microcystin and nodularin into nonhepatocytes, toxins were microinjected into 293 cells, Swiss 3T3 fibroblasts, promyelocytic IPC-81 cells, and NRK cells [6].
  • Nodularin up-regulated induction of c-jun, jun-B,jun-D,c-fos,fos-B, and fra-1 mRNA transcripts in rat liver after i.p. administration, and the accumulation of the mRNA transcripts was sustained for over 9 h after treatment [7].
  • Nodularin induced hyperphosphorylation of cytokeratin peptides 8 and 18 in primary cultured rat hepatocytes 20% more effectively than did microcystin-LR, suggesting that nodularin penetrates more easily into the hepatocytes than does microcystin-LR [7].
  • The potent natural toxins microcystin, nodularin, and okadaic acid act rapidly to induce apoptotic cell death [8].
 

Chemical compound and disease context of Nodularin

 

Biological context of Nodularin

  • Both PP2A and PP1 were potently inhibited (IC50 = 0.026 and 1.8 nM, respectively) by nodularin, whereas PP2B was inhibited to a lesser extent (IC50 = 8.7 microM) [1].
  • Nodularin had no apparent effect on PP2C, alkaline phosphatase, acid phosphatase, insulin receptor tyrosine kinase, protein kinase A, phosphorylase kinase, or protein kinase C. In a whole-cell extract of T51B liver cells, nodularin inhibited PP1 and PP2A activity with a potency similar to that seen with their purified catalytic subunits [1].
  • Characterization of the nodularin synthetase gene cluster and proposed theory of the evolution of cyanobacterial hepatotoxins [13].
  • Subsequently, additional microcystins and nodularin were compared with microcystin-LR on substrate specificity [14].
  • As an extension of this observation, this study was undertaken to investigate the molecular mechanism of downregulation of testosterone and its effect on target organs in Fischer 344 male rats treated with the hepatotoxin nodularin [15].
 

Anatomical context of Nodularin

 

Associations of Nodularin with other chemical compounds

 

Gene context of Nodularin

 

Analytical, diagnostic and therapeutic context of Nodularin

  • Competitive RIA and direct ELISA revealed that the antibodies had good cross-reactivities with an MCYST-arginine-arginine variant (MCYST-RR), MCYST-LR, an MCYST-tyrosine-arginine variant (MCYST-YR), and nodularin (NODLN); but they had lower reactivities with variants MCYST-leucine-tyrosine (MCYST-LY) and MCYST-leucine-alanine (MCYST-LA) [26].
  • Immunoassay methods currently used for microcystin and nodularin detection and analysis do not provide information on the toxicity of microcystin and/or nodularin variants [3].
  • This observation has enabled the design of a specific 16S rRNA PCR for the rapid detection of nodularin-producing strains [27].
  • In vivo EPR oximetry was used to monitor decreasing hepatic pO2 (approximately 2-fold from controls) 2-3 h following nodularin exposure [28].
  • Surface-enhanced laser desorption ionization mass spectrometry (SELDI-TOFMS) was used to develop a new and useful method for determination and identification of the cyanobacterial (blue-green algae) toxins: microcystin and nodularin [29].

References

  1. Cyanobacterial nodularin is a potent inhibitor of type 1 and type 2A protein phosphatases. Honkanen, R.E., Dukelow, M., Zwiller, J., Moore, R.E., Khatra, B.S., Boynton, A.L. Mol. Pharmacol. (1991) [Pubmed]
  2. Conformational studies of microcystin-LR using NMR spectroscopy and molecular dynamics calculations. Trogen, G.B., Annila, A., Eriksson, J., Kontteli, M., Meriluoto, J., Sethson, I., Zdunek, J., Edlund, U. Biochemistry (1996) [Pubmed]
  3. Colorimetric immuno-protein phosphatase inhibition assay for specific detection of microcystins and nodularins of cyanobacteria. Metcalf, J.S., Bell, S.G., Codd, G.A. Appl. Environ. Microbiol. (2001) [Pubmed]
  4. Associations of cyanobacterial toxin, nodularin, with environmental factors and zooplankton in the Baltic Sea. Repka, S., Meyerhöfer, M., von Bröckel, K., Sivonen, K. Microb. Ecol. (2004) [Pubmed]
  5. Detection of nodularin in flounders and cod from the Baltic Sea. Sipiä, V., Kankaanpää, H., Lahti, K., Carmichael, W.W., Meriluoto, J. Environ. Toxicol. (2001) [Pubmed]
  6. Ultrarapid caspase-3 dependent apoptosis induction by serine/threonine phosphatase inhibitors. Fladmark, K.E., Brustugun, O.T., Hovland, R., Boe, R., Gjertsen, B.T., Zhivotovsky, B., Døskeland, S.O. Cell Death Differ. (1999) [Pubmed]
  7. Nodularin, a potent inhibitor of protein phosphatases 1 and 2A, is a new environmental carcinogen in male F344 rat liver. Ohta, T., Sueoka, E., Iida, N., Komori, A., Suganuma, M., Nishiwaki, R., Tatematsu, M., Kim, S.J., Carmichael, W.W., Fujiki, H. Cancer Res. (1994) [Pubmed]
  8. Ca2+/calmodulin-dependent protein kinase II is required for microcystin-induced apoptosis. Fladmark, K.E., Brustugun, O.T., Mellgren, G., Krakstad, C., Boe, R., Vintermyr, O.K., Schulman, H., Doskeland, S.O. J. Biol. Chem. (2002) [Pubmed]
  9. Detection by 32P-postlabelling of 8-oxo-7,8-dihydro-2'-deoxyguanosine in DNA as biomarker of microcystin-LR- and nodularin-induced DNA damage in vitro in primary cultured rat hepatocytes and in vivo in rat liver. Maatouk, I., Bouaïcha, N., Plessis, M.J., Périn, F. Mutat. Res. (2004) [Pubmed]
  10. Nodularin-Har: a new nodularin from Nodularia. Saito, K., Konno, A., Ishii, H., Saito, H., Nishida, F., Abe, T., Chen, C. J. Nat. Prod. (2001) [Pubmed]
  11. Comparative effects and metabolism of two microcystins and nodularin in the brine shrimp Artemia salina. Beattie, K.A., Ressler, J., Wiegand, C., Krause, E., Codd, G.A., Steinberg, C.E., Pflugmacher, S. Aquat. Toxicol. (2003) [Pubmed]
  12. Effects of cyanobacterium Fischerella ambigua isolates and cell free culture media on zebrafish (Danio rerio) embryo development. Wright, A.D., Papendorf, O., König, G.M., Oberemm, A. Chemosphere (2006) [Pubmed]
  13. Characterization of the nodularin synthetase gene cluster and proposed theory of the evolution of cyanobacterial hepatotoxins. Moffitt, M.C., Neilan, B.A. Appl. Environ. Microbiol. (2004) [Pubmed]
  14. Bacterial degradation of microcystins and nodularin. Imanishi, S., Kato, H., Mizuno, M., Tsuji, K., Harada, K. Chem. Res. Toxicol. (2005) [Pubmed]
  15. Marked inhibition of testosterone biosynthesis by the hepatotoxin nodularin due to apoptosis of Leydig cells. Park, T.J., Song, K.Y., Sohn, S.H., Lim, I.K. Mol. Carcinog. (2002) [Pubmed]
  16. Selective left-lobe atrophy by nodularin treatment accompanied by reduced protein phosphatase 1/2A and increased peroxisome proliferation in rat liver. Lim, I.K., Park, T.J., Park, S.C., Yoon, G., Kwak, C.S., Le, M.S., Song, K.Y., Choi, Y.K., Hyun, B.H. Int. J. Cancer (2001) [Pubmed]
  17. Cyanobacteria and prawn farming in northern New South Wales, Australia--a case study on cyanobacteria diversity and hepatotoxin bioaccumulation. Kankaanpää, H.T., Holliday, J., Schröder, H., Goddard, T.J., von Fister, R., Carmichael, W.W. Toxicol. Appl. Pharmacol. (2005) [Pubmed]
  18. Benthic cyanobacteria of the genus Nodularia are non-toxic, without gas vacuoles, able to glide and genetically more diverse than planktonic Nodularia. Lyra, C., Laamanen, M., Lehtimäki, J.M., Surakka, A., Sivonen, K. Int. J. Syst. Evol. Microbiol. (2005) [Pubmed]
  19. In vitro and in vivo effects of protein phosphatase inhibitors, microcystins and nodularin, on mouse skin and fibroblasts. Matsushima, R., Yoshizawa, S., Watanabe, M.F., Harada, K., Furusawa, M., Carmichael, W.W., Fujiki, H. Biochem. Biophys. Res. Commun. (1990) [Pubmed]
  20. Effect of nodularin on the expression of glutathione S-transferase placental form and proliferating cell nuclear antigen in N-nitrosodiethylamine initiated hepatocarcinogenesis in the male Fischer 344 rat. Song, K.Y., Lim, I.K., Park, S.C., Lee, S.O., Park, H.S., Choi, Y.K., Hyun, B.H. Carcinogenesis (1999) [Pubmed]
  21. Influence of microcystin-YR and nodularin on the activity of some proteolytic enzymes in mouse liver. Lankoff, A., Kolataj, A. Toxicon (2001) [Pubmed]
  22. An ultrasensitive competitive binding assay for the detection of toxins affecting protein phosphatases. Serres, M.H., Fladmark, K.E., Døskeland, S.O. Toxicon (2000) [Pubmed]
  23. Microcystin-LR and nodularin induce intracellular glutathione alteration, reactive oxygen species production and lipid peroxidation in primary cultured rat hepatocytes. Bouaïcha, N., Maatouk, I. Toxicol. Lett. (2004) [Pubmed]
  24. Suppression of IL-2 and IL-4 gene expression by nodularin through the reduced NF-AT binding activity. Yea, S.S., Kim, H.M., Jeon, Y.J., Oh, H.M., Jeong, H.G., Yang, K.H. Toxicol. Lett. (2000) [Pubmed]
  25. Multidimensional biochemical detection of microcystins in liquid chromatography. Zeck, A., Weller, M.G., Niessner, R. Anal. Chem. (2001) [Pubmed]
  26. Production and characterization of antibodies against microcystins. Chu, F.S., Huang, X., Wei, R.D., Carmichael, W.W. Appl. Environ. Microbiol. (1989) [Pubmed]
  27. rRNA sequences reflect the ecophysiology and define the toxic cyanobacteria of the genus Nodularia. Moffitt, M.C., Blackburn, S.I., Neilan, B.A. Int. J. Syst. Evol. Microbiol. (2001) [Pubmed]
  28. In vivo assessment of nodularin-induced hepatotoxicity in the rat using magnetic resonance techniques (MRI, MRS and EPR oximetry). Towner, R.A., Sturgeon, S.A., Khan, N., Hou, H., Swartz, H.M. Chem. Biol. Interact. (2002) [Pubmed]
  29. Detection and analysis of the cyanobacterial peptide hepatotoxins microcystin and nodularin using SELDI-TOF mass spectrometry. Yuan, M., Carmichael, W.W. Toxicon (2004) [Pubmed]
 
WikiGenes - Universities